Perspective: cancer vaccines in the era of immune checkpoint blockade

od Cebon, Jonathan
izdano v Mamm Genome (2018)

Delayed Autoimmune Toxicity Occurring Several Months After Cessation of Anti‐PD‐1 Therapy

od Parakh, Sagun, Cebon, Jonathan, Klein, Oliver
izdano v Oncologist (2018)

Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendocrine syndrome type II (APS-2): a case report and review of the literature

od Gunjur, Ashray, Klein, Oliver, Kee, Damien, Cebon, Jonathan
izdano v J Immunother Cancer (2019)

Effects of Epithelial to Mesenchymal Transition on T Cell Targeting of Melanoma Cells

od Woods, Katherine, Pasam, Anupama, Jayachandran, Aparna, Andrews, Miles C., Cebon, Jonathan
izdano v Front Oncol (2014)

Embryonic Chicken Transplantation is a Promising Model for Studying the Invasive Behavior of Melanoma Cells

od Jayachandran, Aparna, McKeown, Sonja J., Woods, Briannyn L., Prithviraj, Prashanth, Cebon, Jonathan
izdano v Front Oncol (2015)

A pilot study of intrahepatic yttrium‐90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver‐only metastases

od Arulananda, Surein, Parakh, Sagun, Palmer, Jodie, Goodwin, Mark, Andrews, Miles C., Cebon, Jonathan
izdano v Cancer Rep (Hoboken) (2019)

The kinase inhibitors dabrafenib and trametinib affect isolated immune cell populations

od Vella, Laura J, Andrews, Miles C, Pasam, Anupama, Woods, Katherine, Behren, Andreas, Cebon, Jonathan S
izdano v Oncoimmunology (2014)

Characterising the phenotypic evolution of circulating tumour cells during treatment

od Tsao, Simon Chang-Hao, Wang, Jing, Wang, Yuling, Behren, Andreas, Cebon, Jonathan, Trau, Matt
izdano v Nat Commun (2018)

Intercellular Resistance to BRAF Inhibition Can Be Mediated by Extracellular Vesicle–Associated PDGFRβ()

od Vella, Laura J., Behren, Andreas, Coleman, Bradley, Greening, David W., Hill, Andrew F., Cebon, Jonathan
izdano v Neoplasia (2017)

A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma

od Ebert, Lisa M., MacRaild, Sarah E., Zanker, Damien, Davis, Ian D., Cebon, Jonathan, Chen, Weisan
Izdano 2012

Phosphoproteomic Analysis of Cell-Based Resistance to BRAF Inhibitor Therapy in Melanoma

od Parker, Robert, Vella, Laura J., Xavier, Dylan, Amirkhani, Ardeshir, Parker, Jimmy, Cebon, Jonathan, Molloy, Mark P.
izdano v Front Oncol (2015)

Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations

od Chang-Hao Tsao, Simon, Weiss, Jonathan, Hudson, Christopher, Christophi, Christopher, Cebon, Jonathan, Behren, Andreas, Dobrovic, Alexander
izdano v Sci Rep (2015)

Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma

od Woods, Katherine, Knights, Ashley J., Anaka, Matthew, Schittenhelm, Ralf B., Purcell, Anthony W., Behren, Andreas, Cebon, Jonathan
izdano v J Immunother Cancer (2016)

Systems analysis identifies miR-29b regulation of invasiveness in melanoma

od Andrews, Miles C., Cursons, Joseph, Hurley, Daniel G., Anaka, Matthew, Cebon, Jonathan S., Behren, Andreas, Crampin, Edmund J.
izdano v Mol Cancer (2016)

PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation

od Tutuka, Candani S. A., Andrews, Miles C., Mariadason, John M., Ioannidis, Paul, Hudson, Christopher, Cebon, Jonathan, Behren, Andreas
izdano v Mol Cancer (2017)

Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion

od Prithviraj, Prashanth, Anaka, Matthew, McKeown, Sonja J, Permezel, Michael, Walkiewicz, Marzena, Cebon, Jonathan, Behren, Andreas, Jayachandran, Aparna
izdano v Oncotarget (2015)

Alternate antigen processing in the presence of gamma interferon may misdirect the immune recognition of cancer

od Woods, Katherine, Schittenhelm, Ralf B, Heesterbeek, Dani, Knights, Ashley, Anaka, Matthew, Purcell, Anthony W, Behren, Andreas, Cebon, Jonathan
izdano v J Immunother Cancer (2015)

Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy

od Prithviraj, Prashanth, McArthur, Grant, Atkinson, Victoria, Parente, Phillip, Andrews, Miles, Parakh, Sagun, Millward, Michael, Cebon, Jonathan, Klein, Oliver
izdano v J Immunother Cancer (2015)

Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report

od Hultin, Sebastian, Nahar, Kazi, Menzies, Alexander M., Long, Georgina V., Fernando, Suran L., Atkinson, Victoria, Cebon, Jonathan, Wong, Muh Geot
izdano v BMC Nephrol (2020)

Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors

od Anaka, Matthew, Hudson, Christopher, Lo, Pu-Han, Do, Hongdo, Caballero, Otavia L, Davis, Ian D, Dobrovic, Alexander, Cebon, Jonathan, Behren, Andreas
Izdano 2013